EUR 6.7m for new endocrine disrupters research centre

The new research centre Endocrine Disruption of Male Reproduction and Child Health at the Copenhagen University Hospital receives Euro 6.7m government grant.

For decades, Danish researchers have been among the pioneers in terms of demonstrating that endocrine disruptors can lead to lower fertility, malformations of the genitalia, testicular cancer and learning disabilities.

Now, the new research centre Endocrine Disruption of Male Reproduction and Child Health (EDmarC) at the Copenhagen University Hospital (Rigshospitalet) is to continue this tradition.

The EDmarC will be chaired by Professor Anders Juul. According to him, the ambition is become one of the world's leading research centres in the field of endocrine disrupters and combination effects and the influence on male reproductive health and children’s health.

The EDmarC has recently received government grants for Euro 6.7m.

“Now that the funding is in place, we are focusing on attracting the best talent in the field such as doctors, chemists and  population study experts in order to create a world-leading research centre within endocrine disrupters and combination effects”, says Anders Juul who will head the EDmarC together with Professor Jorma Toppari from the Turku University, Finland.